Table 2.
ng/dL | IL-1β | IL-1α | IL-6 | IL-2 | TNF-α |
---|---|---|---|---|---|
Ctrl T0 | 0.0074 ± 0.0016 | 0.0711 ± 0.001 | 0.1417 ± 0.0044 | n.a. | n.a. |
Ctrl T1 | 0.0050 ± 0.0014 NS | 0.0640 ± 0.001 NS | 0.1300 ± 0.0038 NS | n.a. | n.a. |
Treat T0 | 0.0650 ± 0.0026 | 0.0350 ± 0.001 | 0.0270 ± 0.0060 | n.a. | n.a. |
Treat T1 | 0.0159 ± 0.0020 * | 0.0541 ± 0.001 NS | 0.0742 ± 0.0070 ** | n.a. | n.a. |
IL-1β = interleukin-1β; IL-1α = interleukin-1α; IL-6 = interleukin-6; IL-2 = interleukin-2; TNF-α = tumor necrosis factor-α; ng/dL = nanograms/deciliters; T0 = time of recruitment; T1 = at the end of the treatment; ctrl = control group, treat = treatment group; NS = not significant; * = p < 0.05; ** = p < 0.01.